These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 879127)
1. Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases. Ishak KG; Kirchner JP; Dhar JK Am J Dig Dis; 1977 Jul; 22(7):611-7. PubMed ID: 879127 [TBL] [Abstract][Full Text] [Related]
2. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906 [TBL] [Abstract][Full Text] [Related]
3. Morphological changes in the liver due to phenazone and its derivatives. Altmann HW Agents Actions Suppl; 1986; 19():267-79. PubMed ID: 3463183 [TBL] [Abstract][Full Text] [Related]
4. Gold-induced granulomatous hepatitis. Harats N; Ehrenfeld M; Shalit M; Lijovetzky G Isr J Med Sci; 1985 Sep; 21(9):753-6. PubMed ID: 3932253 [No Abstract] [Full Text] [Related]
5. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Vanderstigel M; Zafrani ES; Lejonc JL; Schaeffer A; Portos JL Gastroenterology; 1986 Jan; 90(1):188-90. PubMed ID: 3940244 [TBL] [Abstract][Full Text] [Related]
6. Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid. Silvain C; Fort E; Levillain P; Labat-Labourdette J; Beauchant M Dig Dis Sci; 1992 Jan; 37(1):150-2. PubMed ID: 1728522 [TBL] [Abstract][Full Text] [Related]
7. Reversible bone marrow granulomas-adverse effect of oxyphenbutazone therapy. Andersson DE; Langworth S; Newman HC; Ost A Acta Med Scand; 1980; 207(1-2):131-3. PubMed ID: 7368966 [TBL] [Abstract][Full Text] [Related]
8. A compliance study in general practice of patients switched from phenylbutazone and oxyphenbutazone to naproxen and other non-steroidal anti-inflammatory drugs. Dickson DJ; English JR Curr Med Res Opin; 1982; 8(1):61-6. PubMed ID: 6980773 [TBL] [Abstract][Full Text] [Related]
9. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis]. Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862 [TBL] [Abstract][Full Text] [Related]
10. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Zafrani ES; Ishak KG; Rudzki C Dig Dis Sci; 1979 May; 24(5):385-96. PubMed ID: 456225 [TBL] [Abstract][Full Text] [Related]
12. Phenylbutazone and oxyphenbutazone. Med Lett Drugs Ther; 1973 Apr; 15(9):40. PubMed ID: 4704701 [No Abstract] [Full Text] [Related]
13. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. Irani SK; Dobbins WO J Clin Gastroenterol; 1979 Jun; 1(2):131-43. PubMed ID: 400661 [No Abstract] [Full Text] [Related]
14. Hepatic granulomas: a clinicopathologic analysis of 86 cases. Turhan N; Kurt M; Ozderin YO; Kurt OK Pathol Res Pract; 2011 Jun; 207(6):359-65. PubMed ID: 21531083 [TBL] [Abstract][Full Text] [Related]
15. Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. Stricker BH; Blok AP; Bronkhorst FB; Van Parys GE; Desmet VJ J Hepatol; 1986; 3(3):399-406. PubMed ID: 3559147 [TBL] [Abstract][Full Text] [Related]